当前位置: X-MOL 学术Esc Heart Fail. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Effects of luseogliflozin on estimated plasma volume in patients with heart failure with preserved ejection fraction
ESC Heart Failure ( IF 3.8 ) Pub Date : 2021-11-03 , DOI: 10.1002/ehf2.13683
Mitsutaka Nakashima 1 , Toru Miyoshi 1 , Kentaro Ejiri 1, 2 , Hajime Kihara 3 , Yoshiki Hata 4 , Toshihiko Nagano 5 , Atsushi Takaishi 6 , Hironobu Toda 1, 7 , Seiji Nanba 8 , Yoichi Nakamura 9 , Satoshi Akagi 10 , Satoru Sakuragi 11 , Taro Minagawa 12 , Yusuke Kawai 13 , Nobuhiro Nishii 1, 14 , Soichiro Fuke 15 , Masaki Yoshikawa 16 , Kazufumi Nakamura 1 , Hiroshi Ito 1 ,
Affiliation  

Sodium glucose co-transporter 2 inhibitors have diuretic effects in both patients with glycosuria and with natriuresis. We sought to assess the effect of luseogliflozin on estimated plasma volume (ePV) in patients with type 2 diabetes and heart failure with preserved ejection fraction (HFpEF).

中文翻译:

卢塞格列净对射血分数保留的心力衰竭患者估计血浆容量的影响

钠葡萄糖协同转运蛋白 2 抑制剂对糖尿和尿钠排泄的患者都有利尿作用。我们试图评估 luseogliflozin 对射血分数保留的 2 型糖尿病和心力衰竭 (HFpEF) 患者估计血浆容量 (ePV) 的影响。
更新日期:2021-11-03
down
wechat
bug